End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
- RUB | -.--% | -.--% | -.--% |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 |
---|---|---|---|---|---|
Net sales 1 | 162.8 | 194.6 | 245.2 | 259 | 290.2 |
EBITDA 1 | 54.4 | 78.12 | 79.85 | 95.05 | 109.8 |
EBIT 1 | 41.81 | 67.03 | 66.3 | 82.61 | 95.04 |
Operating Margin | 25.67% | 34.44% | 27.04% | 31.89% | 32.75% |
Earnings before Tax (EBT) 1 | 28.6 | 66.94 | 55.57 | 80.52 | 75.26 |
Net income 1 | 28.75 | 52.58 | 61.99 | 82.83 | 70.02 |
Net margin | 17.66% | 27.02% | 25.28% | 31.98% | 24.13% |
EPS 2 | 6.800 | 1.741 | 0.6888 | 0.9203 | 0.7780 |
Free Cash Flow | - | 47.03 | 47.61 | 49.12 | 83.85 |
FCF margin | - | 24.16% | 19.42% | 18.96% | 28.9% |
FCF Conversion (EBITDA) | - | 60.2% | 59.62% | 51.68% | 76.34% |
FCF Conversion (Net income) | - | 89.44% | 76.8% | 59.3% | 119.75% |
Dividend per Share | - | 0.6463 | - | - | - |
Announcement Date | 6/27/21 | 6/27/21 | 6/27/21 | 6/27/21 | 3/1/22 |
Balance Sheet Analysis
Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 |
---|---|---|---|---|---|
Net Debt 1 | 81.8 | 95.6 | 184 | 137 | 172 |
Net Cash position 1 | - | - | - | - | - |
Leverage (Debt/EBITDA) | 1.504 x | 1.223 x | 2.31 x | 1.437 x | 1.564 x |
Free Cash Flow | - | 47 | 47.6 | 49.1 | 83.9 |
ROE (net income / shareholders' equity) | - | 57.4% | 78.7% | 88.4% | 72.3% |
ROA (Net income/ Total Assets) | - | 18.6% | 15.1% | 16.2% | 18.1% |
Assets 1 | - | 282.7 | 410.7 | 509.8 | 386 |
Book Value Per Share 2 | 24.10 | 0.8900 | 0.8500 | 1.290 | 0.9700 |
Cash Flow per Share 2 | 3.530 | 0.1800 | 0.1000 | 0.2300 | 0.3600 |
Capex | - | - | - | - | - |
Capex / Sales | - | - | - | - | - |
Announcement Date | 6/27/21 | 6/27/21 | 6/27/21 | 6/27/21 | 3/1/22 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Chiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-.--% | 393M | |
+20.68% | 85.55B | |
-29.31% | 70.07B | |
+9.65% | 29.06B | |
-8.63% | 17.51B | |
+2.14% | 17.39B | |
+0.39% | 15.38B | |
+6.47% | 13.4B | |
+68.09% | 12.87B | |
+6.43% | 12.77B |
- Stock Market
- Equities
- GEMC Stock
- Financials United Medical Group CY PLC